1178
Can. J. Chem. Vol. 76, 1998
6.78 (brs, 6H, NH), 3.04 (t, 4H, CH2-NH2), 2.80 (t, 4H,
CH2-C6H3(OMe)2), 6.76 (m, 6H, C6H3(OMe)2), 3.87 (s, 6H,
MeO), 3.85 (s, 6H, MeO). MS (FAB): 801 (M+(H2O) –
C3H7N)) (0.2); 788 (MH+(H2O) – (C4H9N)) (0.2), 684 (MH+
– (C3H7N)) (0.1), 744 (M+(H2O) – 2(C3H7N)) (0.2), 716
(M+(H2O) – 2(C4H9N)) (0.1), 703 (M+ – (C8H9O2)) (0.5),
702 (M+ – (C8H10O2)) (1.0), 660 (MH+ – (C10H15NO2))
(0.3), 606 (M+ – 2(C5H11NO2)) (0.1), 566 (M+ – 2(C8H9O2))
(0.5); 565 (M+ – (C8H9O2) – (C8H10O2)) (0.5), 551 (M+ –
(C8H10 O2) – (C9H11O2)) (8.0), 550 (M+ – (C8H10O2) –
(C9H11O2)) (18.0), 479 (MH+ – 2(C10H15NO2)) (39.0), 373
(MH+ – 2(C9H10O2) – 2(C5H10N)) (11.0), 181 (C10H15NO2)+
(9.0), 165 (C10H13O2)+ (66.0), 164 (C10H12O2)+ (31.0), 150
(C9H10O2)+ (11.0), 151 (C9H11O2)+ (21.0), 138 (C8H10O2)+
(17.0), 137 (C8H9O2)+ (31.0), 117 (C5H11NO2)+ (9.0), 73
(C4H11N)+ (100%), 71 (C4H9N)+ (36.0), 57 (C3H7N)+ (70.0).
Anal. calcd. for C40H56N8O12·H2O: C 55.94, H 6.75, N
13.05; found: C 56.33, H 6.49, N 12.94.
6,18-Dimethyl-25(26),27(28)-H,H-3,9,15,21-tetraoxa-
6,18,25,26,27,28-hexaazatricycle[21.2.1.211,13]-octacosa-
1(26),13(28),11,23-tetraen-2,10,14,22-tetraone 3
The suspension obtained above was heated to 60°C under
nitrogen, and a solution of pyrazole-3,5-dicarbonyl chloride
(21 g, 11.46 mmol) in dry dimethoxyethane (80 mL) was
added dropwise. The reaction mixture was kept at 60°C un-
der nitrogen for 24 h. After that, the solvent was removed in
vacuo to give a syrup that was purified by flash column
chromatography, eluting with an ethyl acetate – ethanol –
ammonium hydroxide (5:1:0.15 v/v) mixture. From the frac-
tion of Rf = 0.36, compound 3 was isolated as a pure solid
compound (mp 190–92°C) in 10% yield. IR (KBr, cm–1):
1
3360, 2950, 1725, 1750, 1600, 1250, 1000, 760. H NMR
(300 MHz, Cl3CD (after treated with D2O)), δ (ppm): 7.36
(s, 2H, Pz-H), 4.48 (t, 8H, COOCH2), 2.79 (t, 8H, CH2-
NMe), 2.42 (s, 6H, MeN). MS (FAB): 479 (MH+) (100), 435
(MH+ – C2H4O) (1.0), 422 (MH+ – C3H7N) (3.0), 396 (MH+
– C5H9N) (5.2), 359 (MH+ – C5H2N2O2) (2.0), 341(MH+ –
C5H2N2O3) (8.0), 240 (M+/2 + 1) (7.0), 139 (C5H3N2O3)+
(5.4), 122 (C5H3N2O2)+ (5.4). Anal. calcd. for
C20H26N6O8·2H2O: C 46.69, H 5.83, N 16.34; found: C
46.36, H 5.42, N 16.69.
1
Free homoveratrylamine; H NMR (300 MHz, Cl3CD), δ
(ppm): 1.38 (brs, 2H, NH), 2.92 (t, 2H, CH2NH2), 2.66 (t,
2H, CH2C6H3(OMe)2), 6.75 (m, 3H, C6H3(OMe)2), 3.85 (s,
3H, OMe), 3.83, (s, 3H, OMe).
Molecular modelling
GenMol (11) is a molecular mechanics software including
some specificities, able to treat atomic and molecular sys-
tems till 105 atoms of 96 types: (i) The program uses local
stretching and bending parameters, which depend not only
on the chemical neighbourhood (nature of the bonded atoms,
which is the case in all molecular mechanic programs), but
also of the geometrical neighbourhood. This concept allows
to win an order of magnitude in the geometry accuracy if
compared to X-ray data. (ii) An original algorithm deform-
ing the molecule by rotation around the bonds, and based on
empirical rules deduced from X-ray observations, allow to
very quickly find the most probable conformation of a mole-
cule. (iii) The π systems are taken into account. The pro-
gram calculates the atomic charges.
For the design of the complex, different packing of mole-
cules were tested, and the most stable corresponding to the
minimum of the nonbonded energy (van der Waals,
coulombic, and hydrogen bond) was considered. Then in a
first step, a calculation imposing all the possible hydrogen
bonds was performed, and in a second step these constraints
were removed in order to find the true hydrogen bonds and
the more stable assemblage of the molecules.
Cyclic dinuclear complex 3a
Crown 3 (18 mg, 0.037 mmol) was dissolved at rt in chlo-
roform (5 mL), and a solution of phenethylamine (9.11 mg,
0.075 mmol) in chloroform (2 mL) was added dropwise un-
der stirring. After that, the solvent was removed in vacuo to
give a residue, which was crystallized from acetonitrile, af-
fording the pure dinuclear complex 3a as a white solid (mp
140–142°C) in 90% yield. IR (KBr, cm–1): 3400–3100,
1720, 1630, 1265, 1220, 1035, 795, 760. 1H NMR
(300 MHz, Cl3CD), δ (ppm): 7.31 (s, 2H, Pz-H), 4.40 (m,
8H, COOCH2), 2.70 (m, 8H, CH2-NMe), 2.31 (s, 6H, MeN),
4.70 (brs, 6H, NH), 3.00 (t, 4H, CH2-NH2), 2.80 (t, 4H,
CH2-C6H5), 7.18 (m, 10H, C6H5). MS (FAB): 664 (MH+ –
C3H7N) (0.1), 663 (M+ – C3H7N) (0.2), 606 (M+
2(C3H7N)) (0.1), 600 (MH+ – C8H11N) (0.8), 578 (M+
–
–
2(C4H9N)) (1.9), 567 (MH+ – 2(C6H5)) (0.6), 551 (MH+ –
2(C5H11N)) (11.0), 550 (M+ – 2(C5H11N)) (26.3), 479 (MH+
– 2(C8H11N)) (63.0), 122 (C5H2N2O2)+ (100), 121 (C8H11N)+
(14.0), 77 (C6H5)+ (31.0), 85 (C5H11N)+ (8.0), 71 (C4H9N)+
(14.0), 57 (C3H7N)+ (31.0). Anal. calcd. for
C36H48N8O8·3H2O: C 55.81, H 7.02, N 14.47; found: C
56.12, H 6.62, N 14.32.
Free phenethylamine; 1H NMR (300 MHz, Cl3CD), δ
(ppm): 1.13 (brs, 2H, NH), 2.94 (t, 2H, CH2NH2), 2.72 (t,
2H, CH2C6H5), 7.15 (m, 5H, C6H5).
Financial support of this work by the Spanish Comision
Interministerial de Ciencia y Tecnología (CICYT, Co-
ordinated Project SAF-96–0242-CO2) is gratefully acknowl-
edged.
Cyclic dinuclear complex 3b
Crown 3 (18 mg, 0.037 mmol) was dissolved at rt in chlo-
roform (5 mL), and a solution of homoveratrylamine
(13.63 mg, 0.075 mmol) in chloroform (2 mL) was added
dropwise under stirring. After that, the solvent was removed
in vacuo to give a residue, which was crystallized from
acetonitrile, affording the pure complex 3b in 85% yield as a
white solid (mp 170–172°C). IR (KBr, cm–1): 3480–3200,
2920, 1720, 1635, 1260, 1235, 1035, 785, 760. H NMR
(300 MHz, Cl3CD), δ (ppm): 7.37 (s, 2H, Pz-H), 4.47 (m,
8H, COOCH2), 2.78 (m, 8H, CH2-NMe), 2.38 (s, 6H, MeN),
1. C.D. Klaassen and C.P. O’Brien. In Goodman and Gilman’s
The pharmacological basis of therapeutics. Edited by J.G.
Hardman, L.E. Limbird, P.B. Molinoff, and R.W. Ruddon.
McGraw–Hill, New York. 1996. Chap. 4. p. 63; Chap. 24. p.
557.
1
© 1998 NRC Canada